Meir Lichtenstein
- Surgery
- Pulmonary and Respiratory Medicine
- Radiology, Nuclear Medicine and Imaging top 10%
- Epidemiology
- Neurology top 10%
- Co-authors
- Stephen M. DavisBernard InfeldLouis IrvingPeter MitchellJohn L. HopperGeoffrey A. DonnanDishan H. GunawardanaAlison E. Baird
- Topics
- Radiopharmaceutical Chemistry and Applications (4 papers)Hepatocellular Carcinoma Treatment and Prognosis (4 papers)Acute Ischemic Stroke Management (4 papers)
- Cited by
- HepatologyNephrologyNeurology
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Meir Lichtenstein
34 papers receiving 688 citations
Peers
Comparison fields: 5 of 83
- Surgery 210
- Pulmonary and Respiratory Medicine 190
- Radiology, Nuclear Medicine and Imaging 170
- Epidemiology 141
- Neurology 105
Countries citing papers authored by Meir Lichtenstein
This map shows the geographic impact of Meir Lichtenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meir Lichtenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meir Lichtenstein more than expected).
Fields of papers citing papers by Meir Lichtenstein
This network shows the impact of papers produced by Meir Lichtenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meir Lichtenstein. The network helps show where Meir Lichtenstein may publish in the future.
Co-authorship network of co-authors of Meir Lichtenstein
This figure shows the co-authorship network connecting the top 25 collaborators of Meir Lichtenstein. A scholar is included among the top collaborators of Meir Lichtenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meir Lichtenstein. Meir Lichtenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 6 | |
| 3 | 2 | |
| 4 | 42 | |
| 5 | 12 | |
| 6 | 20 | |
| 7 | 2 | |
| 8 | 11 | |
| 9 | 55 | |
| 10 | 1 | |
| 11 | 27 | |
| 12 | 21 | |
| 13 | 2 | |
| 14 | 14 | |
| 15 | 19 | |
| 16 | Volumetric analysis of cerebral hypoperfusion on SPECT: validation and reliability. | 8 |
| 17 | 22 | |
| 18 | 43 | |
| 19 | 34 | |
| 20 | 12 |
About Meir Lichtenstein
Meir Lichtenstein is a scholar working on Radiology, Nuclear Medicine and Imaging, Hepatology and Nephrology, having authored 35 papers that have together received 715 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Acute Ischemic Stroke Management (4 papers). The work is most often cited by research in Hepatology (69 citations), Nephrology (59 citations) and Neurology (64 citations). Meir Lichtenstein has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Stephen M. Davis, Bernard Infeld, Louis Irving, Peter Mitchell, John L. Hopper, Geoffrey A. Donnan, Dishan H. Gunawardana, Alison E. Baird, David Binns and P. Alan Barber. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Stroke.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.